AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06238349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunbathing
Description: The sunbathing group will receive all interventions prescribed for the control group and be assigned to sunbathing (placement in a bed next to a sunny window) after birth for one week according to the following plan: Every morning and afternoon neonates sunbath for 0.5 to 1 hour to avoid excess sun exposure. Healthcare workers will guide and assist families in their preparations. The caregiver will place a black eye patch on the infants to protect the retina, and a cloth will be wrapped around the hands and feet to prevent scratching, but care will be taken that the wrap is not too tight to avoid circulation disorders. Baby boys will have their genitals covered to protect them from sun damage. After feeding, the newborn will be placed on a sunny platform with fully exposed skin and frequent position changes, while the glass of the window prevent injury from UV light exposure.
Study NCT06238349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunbathing and the Oral bifidobacterium triple live powder
Description: The combination group will receive all interventions of both the group sunbathing and the Bifidobacterium group as well as all interventions prescribed for the control group.
Study NCT06238349 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional treatment
Description: Conventional treatment: Neonates will be placed in an incubator (Ningbo David Medical Device Co., LTD, XHZ model) at 30℃ and relative humidity at 55%. Throughout the study, exclusive breastfeeding and professional care will be provided for the newborns. Newborns requiring phototherapy receive it in the following manner: Phototherapy eye masks (Foshan Forman Medical Technology Co., LTD., Yuesun Mechanical Equipment No. 20160015) and phototherapy diapers (Foshan Baojusheng Medical Equipment Co., LTD., GB/T33280) will be used to cover the eyes and perineum, respectively. Phototherapy was provided via LED blue light continuous irradiation with a wavelength of 425-475nm. All treated neonates will receive continuous phototherapy for 12 hours, then allowe to rest for 6-8 hours, then receive another 12 hours of continuous phototherapy. The decision to continue with further treatment depends on changes in the neonate's jaundice.
Study NCT05393778 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Measured Technique
Description: Manual intra-operative checks and tools are used to aid in component placement during surgery.
Study NCT05393778 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Navigated Technique
Description: IntelliJoint® navigation is an imageless-based navigation system that utilizes a miniature infrared camera and microelectronics to measure hip center of rotation, acetabular inclination and version, leg length, and offset. The device provides accurate real-time data on implant positioning to aid in placement of the components during surgery.
Study NCT06343493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Normal saline heated up to 50 °C
Description: Saline heated up to 50 °C used for irrigation
Study NCT05302882 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Myofascial release
Description: The physiotherapist placed both palms on the two right and left ribs at the T12 level and applied continuous stretching to the superior for 2 minutes. After this application, the physiotherapist placed one hand on the sacrum with the other hand on T12 with his hands crossed, and applied rhythmically 2 seconds of stretching and 2 seconds of relaxation for a total of 2 minutes. Then, myofascial release was terminated by applying deep compression to the paraspinal muscles with palms for 2 minutes on the right and 2 minutes on the left side, respectively.
Study NCT05302882 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Classical massage
Description: Classical massage was applied to the lumbar region for 9 minutes. Classical massage was applied with the patient in the prone position. A small amount of solid vaseline was taken and a gentle stroke was applied for 1 minute to spread it sufficiently to the lumbar region. Then, superficial stroking was applied to the right paraspinal region for 1 minute from distal to proximal by the physiotherapist. After the same procedure was performed on the right paraspinal region for 1 minute. Then, both hands were placed on the right and left paraspinal region and friction was applied for 2 minutes. Afterwards, the patient's right paraspinal region was kneeding for 1 minute and then the same procedure was applied to the left paraspinal region for 1 minute. As the last procedure, the fingertips of both hands were placed on the right and left paraspinal region and the classical massage was completed by performing 2 minutes of deep euphlorage from the L5-S1 level to the T12 level.
Study NCT06148636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [212Pb] VMT-α-NET
Description: Up to 2 infusions with \[212Pb\] VMT-α-NET, each infusion separated by at least 8 weeks. During each infusion, the participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage.
Study NCT05439512 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transantral orbital floor reconstruction by titanium mesh
Description: reconstruction of orbital floor fracture by patient specific titanium mesh
Study NCT06148636 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [203Pb] VMT-α-NET SPECT/CT
Description: The \[203Pb\] VMT-α-NET SPECT/CT is performed for all participants to determine trial eligibility as well as for the calculations to determine the estimated radiation dose to kidneys. This involves three imaging sessions of about 2 hours each over 2 days. The participants also receive an infusion with lysine and arginine (amino acids) to help reduce kidney damage at the time they receive the injection of . \[203Pb\] VMT-α-NET, a radioactive tracer drug.
Study NCT04854967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rescind home oxygen order
Description: A note will be entered in the medical record describing the participants randomization into the intervention group. The note will be signed by study staff and will accompany the discontinuation of the patient's home oxygen by a study clinician.
Study NCT05558163 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: transverse scrotal approach for PPI
Description: penile prothesis implantation through penoscrotal approach outcome
Study NCT04854967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Provider Education
Description: A note will be entered in the medical record informing the patient's individual medical providers (i.e. primary care provider, pulmonologist) of their randomization into the intervention group. The note will include the evidence-base for oxygen use among patients with COPD.
Study NCT04854967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Education
Description: The patient will receive a patient education page about discontinuation of home oxygen after recovery from a hospitalization that was developed by Consumer Reports in conjunction with the Choosing Wisely Campaign.
Study NCT04854967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teach-to-goal inhaler training
Description: Teach-to-goal (TTG) inhaler training is a patient-centered education strategy that has been shown to decrease inhaler misuse and decrease acute care utilization. The training is tailored to the patient and meets guideline recommendations for assessment and instruction of inhaler technique. The rounds of assessment and demonstration can be completed until acceptable skill level is attained and tailored to the specific medication prescribed.
Study NCT04854967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pursed lip breathing
Description: Pursed lip-breathing will be taught to the participants randomized to the intervention arm. This simple technique relieves breathlessness and has been shown to improve functional capacity in patients with COPD. Participants will be given an instructional handout to refer to after the visit.
Study NCT05558163 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: penoscrotal approach for PPI
Description: penile prothesis implantation through penoscrotal approach outcome
Study NCT05286307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPACK block
Description: IPACK block with 20 mL of 0.25% Bupivacaine injected into the Interspace between the Popliteal Artery and Capsule of the Knee
Study NCT05546957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Administered orally once per day (QD)
Study NCT05546957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rivaroxaban low dose
Description: Administered orally twice per day (BID)
Study NCT05162352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib+sintilimab
Description: Part 1 (Safety Run-in): donafenib 200mg P.O. BID and sintilimab 200mg I.V. for a 21-days cycle.~Part 2: donafenib at the recommended phase 2 dose determined from Part 1 and sintilimab 200mg I.V. Q3W.~Donafenib will last until disease progresses, intolerable toxicity, withdrawal of informed consent, loss of follow-up, death, or other circumstances that require termination of treatment, whichever occurs first. Sintilimab will last up to 24 months, or until disease progresses, intolerable toxicity, withdrawal of informed consent, loss of follow-up, death, or other circumstances that require termination of treatment, whichever occurs first. Patients will be allowed to have donafenib or sintilimab as a sigle agent and will be still considered on study when the other drug cause intolerable toxicity.
Study NCT05546957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rivaroxaban high dose
Description: Administered orally QD
Study NCT05879276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: Patients in cardiogenic shock receiving empagliflozin in addition to standard management at a dose of 10 mg per day per os (or through nasogastric tube in intubated patients) for a duration of 12 weeks.
Study NCT05267093 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Sterile single-use stainless steel needles (size 0.3 mm × 25 mm) will be utilized. After local skin disinfection with 75% alcohol wipes, acupuncturists will insert needles perpendicularly into the Ashi points to a depth of approximately 2-3 mm; horizontally into the Baxie points toward the wrist to a depth of 5-10 mm; and perpendicularly into Houxi (SI3) and Waiguan (TE5) to a depth of approximately 5-10 mm. The depth of needling will vary based on the participant's body sizes. After insertion, all needles except those in the Ashi points will be manually manipulated to achieve De qi sensations. All the needles will be retained for 30 min and then gently removed. Participants will take acupuncture treatment three times per week for a total of 12 sessions in 4 consecutive weeks.
Study NCT05267093 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Sham acupuncture
Description: The sham needles with blunt tips (size 0.3 mm × 25 mm) will be used in the control group. Acupuncturists will gently lift and twist the sham needles to simulate the treatment procedure, thus blinding the patients to the intervention. Acupuncturist will firstly sterilize the areas of acupoints, then apply the adhesive pads on the surface of Ashi points, Baxie points, Houxi (SI3) and Waiguan (TE5) and insert the sham needles without penetrating. The duration and frequency of treatment sessions will be the same as in the acupuncture group.
Study NCT05594732 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weak outdoor light
Description: Stay and stare far on the balcony or under the tree
Study NCT05594732 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strong outdoor light
Description: Stay and stare far in the sunlight
Study NCT04958837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FIFA 11+ protocol with additional Core training exercises
Description: Slow paced running exercises of 8 minutes' duration (2 rounds each), followed by Strength, plyometric and balance exercises including 3 sets of 20-30 sec of The Bench, Sideways Bench each side, Nordic Hamstring strengthening, single leg stance balance training, squatting and high speed running. The protocol will end with additional core training exercises including leg raises, crunches, superman, plank hip twist, and supine bridge. Each exercise plan will be progressively increased. Core training will be followed by 30 sec stretch of major muscle groups.
Study NCT04958837 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FIFA 11+ protocol
Description: Slow paced running exercises of 8 minutes' duration including running straight, running with hip out, running hip in, running circling partner, running shoulder contact and running quickly forward and backwards (2 rounds each), followed by Strength, plyometric and balance exercises including The Bench, Sideways Bench each side, Nordic Hamstring strengthening and single leg stance balance training, squatting and jumping. All exercises will be progressively increased as per established protocol. The final phase of the study includes fast running for 2 minutes.
Study NCT06287957 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Labrida BioClean
Description: Debriding the tissue around the implant with Labrida Bioclean
Study NCT06287957 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: EMS Handy 3.0 Perio Premium
Description: Debriding the tissue around the implant with Air-Flow Device
Study NCT05675124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Needlescopic laparoscopic adrenalectomy
Description: Compared with traditional laparoscopic surgery using 5-12 mm instruments, the wound of needlescopic laparoscopic surgery is smaller. Postoperative pain and recovery are also better than traditional laparoscopic surgery.
Study NCT05675124 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: conventional laparoscopic adrenalectomy
Description: conventional laparoscopic adrenalectomy
Study NCT06439342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maribavir
Description: Maribavir tablets
Study NCT05299034 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multiparametric imaging
Description: MR perfusion or multiparametric CT including NCCT, CTA and CTP
Study NCT05299034 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Non contrast CT+CT angiography
Description: NCCT+CTA
Study NCT05089487 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nocturnal rest (sleep study)
Description: Proportion of patients free of severe hypoxemia without oxygen therapy during nocturnal rest .
Study NCT05124587 — intervention group
Intervention type: OTHER
Intervention: No intervention group
Description: No intervention group
Study NCT06225648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: threonine
Description: There are 7 different threonine test levels ranging from 5 to 45 mg of threonine per kilogram body weight per day.
Study NCT05089487 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nocturnal rest (sleep study)
Description: Proportion of patients free of severe hypoxemia without oxygen therapy during nocturnal rest .
Study NCT04769141 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: CURATE.AI
Description: CURATE.AI is one example of an artificial intelligence guided dosing decision tool. It is customized to each individual and can be applicable across many different conditions, as it is disease agnostic.~This platform has already demonstrated initial success in cancer and transplant populations but yet to be applied to chronic disease patients.
Study NCT04241536 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood draw and urine collection
Description: Patients will collect blood and urine for metabolome analysis
Study NCT05585632 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1010
Description: Sterile liquid for injection
Study NCT05585632 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1345
Description: Sterile liquid for injection
Study NCT04328181 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spectral Photon Counting Computed Tomography (SPCCT)
Description: For the dual-layer spectral CT scanner (IQon®, Philips, Amsterdam, The Netherlands), the following parameters will be used for the acquisition:~* Tube potential 120 kVp;~* Tube current time product of 150 mAs;~* Gantry revolution time 0.33 s;~* Automatic exposure control (angular and longitudinal) combined xyz-axis;~* Beam collimation geometry 64 x 0.625 mm - scan field-of-view - 22 cm;
Study NCT04328181 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DECT (Dual Energy CT)
Description: The SPCCT scanner is a prototype spectral photon-counting computed tomography system derived from a modified clinical CT system with a field-of-view (FOV) of 168 mm in-plane, and a z-coverage of 20 mm. It is equipped with energy-sensitive photon-counting detectors relying on the direct conversion high band gap semiconductor of cadmium zinc telluride (CZT). The electronics comprises 5 rate counters with 5 different configurable energy thresholds. The SPCCT scanner has the following parameters:~* Base platform : iCT scanner~* Tube Voltage (kVp) : 120, capability for imaging at 80 and 100 kVp~* Tube current (mA) : 10 - 300~* Spatial Resolution : > 30 lp/cm, ≤ 250 µm~* Z-coverage isocenter (mm) : 20 mm~* FOV (mm) : 500~* Minimum rotation time : 0.33 s/rotation~* Acquisition modes : Axial, Helical, Step \& Shoot
Study NCT05585632 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273.214
Description: Sterile liquid for injection
Study NCT05585632 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1045
Description: Formulation for injection
Study NCT05585632 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1230
Description: Formulation for injection
Study NCT06089772 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comparing to Manipulation and Myofascial Release Techniques
Description: Randomized Controlled Trials
Study NCT06089772 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Comparing to Manipulation and Myofascial Release Techniques
Description: Randomized Controlled Trials
Study NCT05656066 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Vibration Intervention
Description: The vibration frequency of the massager, which accelerates blood circulation, is 6000 / min, it works with a 1.5 volt battery. Can be used easily with one hand. The vibration simulator design is based on the gate-control theory, which allows for a reduction in the perceived amount of pain experienced during injection by closing the pain gate in the spinal cord in creating a stimulus on the skin.
Study NCT05656066 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Pressure Intervention
Description: Pressure was placed in the ıntramuscular area properly 30 seconds before injection. Then the injection process was completed.
Study NCT06089772 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Comparing to Manipulation and Myofascial Release Techniques
Description: Randomized Controlled Trials
Study NCT05193292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: 200mg, iv, 21d for a treatment cycle
Study NCT05193292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: 8 mg/kg loading dose, followed by 6 mg/kg maintenance, iv, 21d for a treatment cycle
Study NCT05193292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX regimen
Description: Oxaliplatin, 130 mg/m2, iv, d1; Capecitabine, 1000 mg/m2, po, bid, d1-d14; q3w
Study NCT05193292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX6 regimen
Description: Oxaliplatin, 85 mg/m2, iv, d1; Leucovorin, 400 mg/m2, iv, d1; 5-FU, 400mg/m2, iv, d1 followed by 1200 mg/(m2·d)\*2d, civ, 46h; q2w
Study NCT05193292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen
Description: Irinotecan, 180 mg/m2, iv, d1; Leucovorin, 400 mg/m2, iv, d1; 5-FU, 400mg/m2, iv, d1 followed by 1200 mg/(m2·d)\*2d, civ, 46h; q2w
Study NCT05193292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mXELIRI regimen
Description: Irinotecan, 200 mg/m2, iv, d1; capecitabine, 800 mg/m2, po, bid, d1-d14; q3w
Study NCT05193292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mIRIS regimen
Description: Irinotecan, 180 mg/m2, iv, d1; Tiggio Capsules (S-1), 40-60 mg/m2, po, bid, d1-d9; q2w
Study NCT06318559 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 3D Robot-assisted laparoscopic radical prostatectomy and pelvic lymphadenectomy
Description: The operation is performed using the Da Vinci HD robotic system which allows the use of laparoscopic instruments, with greater mobility and the possibility of easier and more precise control of movements in three dimensions. Furthermore, the system allows the surgeon a three-dimensional view of the operating field. The surgery is performed under general anesthesia. Six or more trocars are positioned, into which the instruments operated by the robot or directly by the surgical assistants are inserted.~Then a radical prostatectomy is performed.
Study NCT06184165 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Personalized rTMS
Description: 5 personalized targets accessible to TMS (at less than 3.5 cm distance from the scalp or the coil's hot spot) are placed in the hyper-perfused premotor regions.~The patient is installed on the robotic device. The technician puts a neuro-navigation tracker on the subject's forehead and proceeds to the co-registration. The motor threshold is defined, and stimulator output's intensity is adjusted accordingly (120%) The robotic system ensures that the actual stimulation is performed according to the personalized protocol. This adequacy will be evaluated secondarily based on the recordings of the coil positions during each